Meta-analysis of the association between cysticercosis and epilepsy in Africa

Epilepsia

Volumn 51, Issue 5, 2010, Pages 830-837

  Quet, Fabrice ^a   Guerchet, Maëlenn ^a   Pion, Sebastien D S ^a,b   Ngoungou, Edgard B ^a,c   Nicoletti, Alessandra ^d   Preux, Pierre Marie ^a  

^a UNIVERSITÉ DE LIMOGES   (France)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^c UNIVERSITÉ DES SCIENCES DE LA SANTÉ   (Gabon)

^d UNIVERSITY OF CATANIA   (Italy)

Author keywords

Africa; Cysticercosis; Epilepsy; Meta analysis

Indexed keywords

AFRICA; ARTICLE; CLINICAL TRIAL; CYSTICERCOSIS; DISEASE ASSOCIATION; EPILEPSY; HUMAN; META ANALYSIS; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; SERODIAGNOSIS; SYSTEMATIC REVIEW; TAENIA SOLIUM;

AFRICA; CASE-CONTROL STUDIES; COMORBIDITY; CYSTICERCOSIS; EPILEPSY; FEMALE; HUMANS; MALE; NEUROCYSTICERCOSIS; PREGNANCY; PREVALENCE; RISK FACTORS;

EID: 77951538390     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2009.02401.x     Document Type: Article

References (50)

1. Adjidé CC, Bouteille B, Josse R, Adjidé-Szmidt V, Avodé DG, Dumas M. (1996) Séroprévalence de la cysticercose dans la commune lacustre de Vekky, département de l'Atlantique (Bénin). Bull Soc Pathol Exot 89:24-29.
2. Andriantsimahavandy A, Lesbordes JL, Rasoaharimalala B, Peghini M, Rabarijaona L, Roux J, Boisier P. (1997) Neurocysticercosis: a major aetiological factor of late-onset epilepsy in Madagascar. Trop Med Int Health 8:741-746. (Pubitemid 27347989)
3. Avodé DG, Bouteille B, Houngbe F, Adjien C, Adjide C, Houinato D, Hountondjil A, Dumas M. (1998) Epilepsy, cysticercosis and neurocysticercosis in Benin. Eur Neurol 36:60-61.
4. Balogou AA, Grunitzky KE, Beketi KA, Bouteille B, Dumas M. (2000) Cysticercose et épilepsie au nord du Togo dans le Tone. Rev Neurol 156:270-273. (Pubitemid 30169558)
5. Bouteille B, Preux PM, Grunitzky EK, Avode DG, Hegbe M, Adjien KC, Dabis F, Dumas M. (1994) Epidemiological study of cysticercosis/epilepsy linkage in Benin and Togo, West Africa. 19ème Réunion Scientifique de l'Association des Epidémiologistes de Langue Française (ADELF), Rennes, France, 28-30 septembre 1994.
6. Carpio A, Escobar A, Hauser WA. (1998) Cysticercosis and epilepsy: a critical review. Epilepsia 39:1025-1040.
7. Commission on Epidemiology, Prognosis of the International League Against Epilepsy. (1993) Guidelines for epidemiologic studies on epilepsy. Epilepsia 34:592-596.
8. Cucherat M, Boissel JP, Leizorovicz A, Haugh MC. (1997) EasyMA: a program for the meta-analysis of clinical trials. Comput Methods Programs Biomed 53:187-190. (Pubitemid 27305437)
9. Del Brutto OH, Wadia NH, Dumas M, Cruz M, Tsang VCW, Schantz PM. (1996) Proposal of criteria for human cysticercosis and neurocysticercosis. J Neurol Sci 142:1-6. (Pubitemid 26340400)
10. Del Brutto OH, Rajshekhar V, White AC Jr, Tsang VC, Nash TE, Takayanagui OM, Schantz PM, Evans CA, Flisser A, Correa D, Botero D, Allan JC, Sarti E, Gonzalez AE, Gilman RH, Garcia HH. (2001) Proposed diagnostic criteria for neurocysticercosis. Neurology 57:177-183.
11. Del Brutto OH. (2005) Neurocysticercosis. Semin Neurol 25:243-251.
12. Del Brutto OH, Santibanez R, Idrovo L, Rodriguez S, Diaz-Calderon E, Navas C, Gilman RH, Cuesta F, Mosquera A, Gonzalez AE, Tsang VC, Garcia HH. (2005) Epilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal Ecuador. Epilepsia 46:583-587. (Pubitemid 40470684)
13. Diop AG, Hesdorffer DC, Logroscino G, Hauser WA. (2005) Epilepsy and mortality in Africa: a review of the literature. Epilepsia 46:33-35. (Pubitemid 44922034)
14. Diwan AR, Coker-Vann M, Brown P, Subianto DB, Yolken R, Desowitz R, Escobar A, Gibbs CJ Jr, Gajdusek DC. (1982) Enzyme-linked immunosorbent assay (ELISA) for the detection of antibody to cysticerci of Taenia solium. Am J Trop Med Hyg 31:364-369. (Pubitemid 12112461)
15. Dongmo L, Druet-Cabanac M, Moyou SR, Zebaze DRM, Njamnshi AK, Sini V, Mapoure N, Echouffo TJB, Djeumen WC, Ndumbe PM. (2004) Cysticercose et épilepsie: étude cas-témoins dans la Vallée du Mbam, Cameroun. Bull Soc Pathol Exot 97:105-108.
16. Druet-Cabanac M, Ramanankandrasana B, Bisser S, Dongmo L, Avodé G, Nzisabira L, Dumas M, Preux PM. (2002) Taenia solium cysticercosis in Africa. In Singh G, Prabhakar S (Eds) Taenia solium cysticercosis. From basic to clinical science. CABI Publishing, New York, pp. 129-137.
17. Dumas M, Grunitzky E, Deniau M, Dabis F, Bouteille B, Belo M, Pestre-Alexandre M, Catanzano G, Darde ML, D'Almeida M. (1989) Epidemiological study of neuro-cysticercosis in Northern Togo (West Africa). Acta Leiden 57:191-196.
18. Erhart A, Dorny P, Van De N, Vien HV, Thach DC, Toan ND, Cong le D, Geerts S, Speybroeck N, Berkvens D, Brandt J. (2002) Taenia solium cysticercosis in a village in northern Viet Nam: seroprevalence study using an ELISA for detecting circulating antigen. Trans R Soc Trop Med Hyg 96:270-272. (Pubitemid 34785061)
19. Garcia HH, Gilman R, Martinez M, Tsang VC, Pilcher JB, Herrera G, Diaz F, Alvarado M, Miranda E. (1993) Cysticercosis as a major cause of epilepsy in Peru. The Cysticercosis Working Group in Peru (CWG). Lancet 341:197-200. (Pubitemid 23048081)
20. Grill J, Rakotomalala W, Andriantsimahavandy A, Boisier P, Guyon P, Roux J, Esterre P. (1996) High prevalence of serological markers of cysticercosis among epileptic Malagasy children. Ann Trop Paediatr 16:185-191. (Pubitemid 26317146)
21. Grunitzky E, Balogou AK, M'Bella M, Belo M, Sadzo A, Bouteille B, Dumas M. (1995) La cysticercose chez des malades neurologiques en milieu hospitalier à Lomé, Togo. Ann Med Interne 146:419-422.
22. Heinz HJ, Klintworth G. (1965) Cysticercosis in the aetiology of epilepsy. S Afr J Med Sci 30:32-36.
23. Ito A, Yamasaki H, Nakao M, Sako Y, Okamoto M, Sato MO, Nakaya K, Margono SS, Ikejima T, Kassuku AA, Afonso SM, Ortiz WB, Plancarte A, Zoli A, Geerts S, Craig PS. (2003) Multiple genotypes of Taenia solium/ramifications for diagnosis, treatment and control. Acta Trop 87:95-101. (Pubitemid 36629488)
24. Jacoby A, Austin JK. (2007) Social stigma for adults and children with epilepsy. Epilepsia 48(suppl 9):6-9. (Pubitemid 350198218)
25. Kamgno J, Pion SD, Boussinesq M. (2003) Demographic impact of epilepsy in Africa: results of a 10-year cohort study in a rural area of Cameroon. Epilepsia 44:956-963.
26. Lightowlers MW. (2006) Cestode vaccines: origins, current status and future prospects. Parasitology 133:S27-S42.
27. Mignard C, Mignard D, Dandelot JB, Polydor JP, Laporte JP, Bousquet C, Choucair Y, Michault A. (1986) Etude épidémiologique de la cysticercose endémique à l'ile de la réunion. Rev Neurol 142:635-637.
28. Montano SM, Villaran MV, Ylquimiche L, Figueroa JJ, Rodriguez S, Bautista CT, Gonzalez AE, Tsang VC, Gilman RH, Garcia HH, Cysticercosis Working Group in Peru. (2005) Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru. Neurology 65:229-233.
29. Morales J, Martínez JJ, Manoutcharian K, Hernández M, Fleury A, Gevorkian G, Acero G, Blancas A, Toledo A, Cervantes J, Maza V, Quet F, Bonnabau H, de Aluja AS, Fragoso G, Larralde C, Sciutto E. (2008) Inexpensive anti-cysticercosis vaccine: S3Pvac expressed in heat inactivated M13 filamentous phage proves effective against naturally acquired Taenia solium porcine cysticercosis. Vaccine 26:2899-2905.
30. Nakao M, Okamoto M, Sako Y, Yamasaki H, Nakaya K, Ito A. (2002) A phylogenetic hypothesis for the distribution of two genotypes of the pig tapeworm Taenia solium worldwide. Parasitology 124:657-662. (Pubitemid 34752178)
31. Nash TE, Pretell EJ, Lescano AG, Bustos JA, Gilman RH, Gonzalez AE, Garcia HH, Cysticercosis working group in Peru. (2008) Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol 7:1099-1105.
32. Newell E, Vyungimana F, Geerts S, Van Kerckhoven I, Tsang VCW, Engels D. (1997) Prevalence of cysticercosis in epileptics and members of their families in Burundi. Trans R Soc Trop Med Hyg 91:389-391. (Pubitemid 27421216)
33. Nicoletti A, Bartoloni A, Sofia V, Bartalesi F, Chavez JR, Osinaga R, Parasidi F, Dumas JL, Tsang VC, Reggio A, Hall AJ. (2005) Epilepsy and neurocysticercosis in rural Bolivia: a population-based survey. Epilepsia 46:1127-1132. (Pubitemid 40962159)
34. Nsengiyumva G, Druet-Cabanac M, Ramanankandrasana B, Bouteille B, Nsizabira L, Preux PM. (2003) Cysticercosis as a major risk factor for epilepsy in Burundi, East Africa. Epilepsia 44:950-955. (Pubitemid 36842186)
35. Nzisabira L, Nsengiyumva G, Bouteille B, Ndayiragije A, Niyongabo TH, Bigirimana V, Dumas M, Aubry P. (1992) La cysticercose dans la province de Kayanza (Burundi). Bull Soc Pathol Exot 85:374-377.
36. Pal DK, Carpio A, Sander JWAS. (2000) Neurocysticercosis and epilepsy in developing countries. J Neurol Neurosurg Psychiatry 68:137-143.
37. Powell SJ, Proctor EM, Wilmot AJ, MacLeod IN. (1966) Cysticercosis and epilepsy in Africans: a clinical and serological study. Ann Trop Med Parasitol 60:152-158.
38. Prado-Jean A, Kanobana K, Druet-Cabanac M, Nsengyiumva G, Dorny P, Preux PM, Geerts S. (2007) Combined use of an antigen and antibody detection enzyme-linked immunosorbent assay for cysticercosis as tools in an epidemiological study of epilepsy in Burundi. Trop Med Int Health 12:895-901. (Pubitemid 46998288)
39. Preux PM, Melaku Z, Druet-Cabanac M, Avode GD, Grunitzky EK, Bouteille B, Cruz M, Dumas M. (1996) Cysticercosis and neurocysticercosis in Africa: current status. Neurol Infect Epidemiol 1:63-68.
40. Singh G. (1997) Neurocysticercosis in South-Central America and the Indian subcontinent. A comparative evaluation. Arq Neuropsiquiatr 55:349-356.
41. Singh G, Sachdev MS, Tirath A, Gupta Ak, Avasthi G. (2000) Focal cortical-subcortical calcifications (FCSCs) and epilepsy in the Indian subcontinent. Epilepsia 41:718-726. (Pubitemid 30390425)
42. Van As AD, Joubert J. (1991) Neurocysticercosis in 578 black epileptic patients. S Afr Med J 80:327-328.
43. Waruingi M, Ramanankandrasana B, Druet-Cabanac M, Nsengiyumva G, Bouteille B, Preux PM. (2002) Kenya: a new human cysticercosis focus. Afr J Neurol Sci 21:46. (Pubitemid 41289238)
44. White AC. (1997) Neurocysticercosis: a major cause of neurological disease worldwide. Clin Infect Dis 24:101-115.
45. WHO. (1981) Research protocol for measuring the prevalence of neurological disorders in developing countries. Neurosciences programme. World Health Organization, Geneva.
46. Wilson M, Bryan RT, Fried JA, Ware DA, Schantz PM, Pilcher JB, Tsang VC. (1991) Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. J Infect Dis 164:1007-1009.
47. Winkler AS, Schaffert M, Schmutzhard E. (2007) Epilepsy in resource poor countries-suggestion of an adjusted classification. Epilepsia 48:1029-1030. (Pubitemid 46763394)
48. Winkler AS, Blocher J, Auer H, Gotwald T, Matuja W, Schmutzhard E. (2008) Anticysticercal and antitoxocaral antibodies in people with epilepsy in rural Tanzania. Trans R Soc Trop Med Hyg 102: 1032-1038.
49. Winkler AS, Blocher J, Auer H, Gotwald T, Matuja W, Schmutzhard E. (2009) Epilepsy and neurocysticercosis in rural Tanzania-An imaging study. Epilepsia 50:987-993.
50. Zoli AP, Nguekam JP, Shey-Njila O, Nsame Nforninwe D, Speybroeck N, Ito A, Sato MO, Dorny P, Brandt J, Geerts S. (2003) Neurocysticercosis and epilepsy in Cameroon. Trans R Soc Trop Med Hyg 97:683-686.